Psoriasis and Psoriatic Arthritis Stelara is given as a subcutaneous injection initially and 4 weeks later, then a dose is given every 12 weeks. Dose is dependent on the patient's weight. For more Stelara dosing information, click on the link below.
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. Stelara is an interleukin inhibitor
For the treatment of plaque psoriasis, STELARA is administered by subcutaneous injection. The recommended dose of STELARA is 45 mg administered at Weeks 0 and 4
the diseases that Stelara is used for . In plaque psoriasis and psoriatic arthritis, Stelara is injected under the skin. For adults the usual dose is 45 mg, whereas in children with plaque psoriasis the dose depends on their bodyweight. The dose in patients weighing over 100 kg is 90 mg for psoriasis, and this dose may also be considered for
REMICADE dosing administration for adult patients with chronic severe plaque psoriasis. See STELARA (ustekinumab) Please see full Prescribing
Plaque psoriasis and psoriatic arthritis Stelara is given initially as a subcutaneous injection for the first dose, and then again 4 weeks
Stelara (ustekinumab) Injection and Skyrizi (risankizumab-rzaa) are used to treat plaque psoriasis.
WHAT IS STELARA (ustekinumab)?. STELARA is a prescription medicine used to treat: adults and children 6 years and older with moderate to severe psoriasis who
Plaque psoriasis and psoriatic arthritis Stelara is given initially as a subcutaneous injection for the first dose, and then again 4 weeks
Comments